Connor, Clark & Lunn Investment Management (CC&L)
INZY

Connor, Clark & Lunn Investment Management (CC&L)’s Inozyme Pharma INZY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio INZY Stock Details INZY Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,832
Closed -$267K – 1521
2024
Q1 		$267K Buy
+34,832
New +$267K ﹤0.01% 1309